These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36658445)

  • 1. Reply to the comment on "Fluid restriction in management of patent ductus arteriosus in Italy: a nationwide survey".
    Francescato G; Capolupo I; Cerbo RM; Doni D; Ficial B; Fiocchi S; Matina F; Milani GP; Mizzoni F; Salvadori S; Savoia M; Corsini I
    Eur J Pediatr; 2023 Apr; 182(4):1931-1932. PubMed ID: 36658445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluid restriction in management of patent ductus arteriosus in Italy: a nationwide survey.
    Francescato G; Capolupo I; Cerbo RM; Doni D; Ficial B; Fiocchi S; Matina F; Milani GP; Mizzoni F; Salvadori S; Savoia M; Corsini I
    Eur J Pediatr; 2023 Jan; 182(1):393-401. PubMed ID: 36374300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of hemodynamically significant patent ductus arteriosus on acute kidney injury and systemic hypertension in extremely low gestational age newborns.
    Velazquez DM; Reidy KJ; Sharma M; Kim M; Vega M; Havranek T
    J Matern Fetal Neonatal Med; 2019 Oct; 32(19):3209-3214. PubMed ID: 29642731
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluid and electrolyte management in preterm infants with patent ductus arteriosus.
    Lalitha R; Surak A; Bitar E; Hyderi A; Kumaran K
    J Neonatal Perinatal Med; 2022; 15(4):689-697. PubMed ID: 35599502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of Conservative Approach for Persistent Patent Ductus Arteriosus in Preterm Infants: Neurodevelopmental Outcomes at 5 Years of Age.
    Kaga M; Sanjo M; Sato T; Miura Y; Ono T
    Tohoku J Exp Med; 2019 Nov; 249(3):155-161. PubMed ID: 31708567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and echocardiographic characteristics associated with evolution of patent ductus arteriosus in preterm neonates: A prospective cohort study.
    Saha AK; Sardar SK; Majhi B; Chatterjee S
    J Neonatal Perinatal Med; 2022; 15(3):537-544. PubMed ID: 35599501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comment on "Fluid restriction in management of patent ductus arteriosus in Italy: a nationwide survey".
    Liu C; Shi Y
    Eur J Pediatr; 2023 Jan; 182(1):469-470. PubMed ID: 36454298
    [No Abstract]   [Full Text] [Related]  

  • 8. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Shah SS
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004213. PubMed ID: 31985838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Shah SS
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD004213. PubMed ID: 31222841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patent Ductus Arteriosus and the Effects of Its Late Closure in Preterm Infants with Severe Bronchopulmonary Dysplasia.
    Ansems SM; Kirpalani H; Mercer-Rosa L; Wang Y; Hopper RK; Fraga MV; Jensen EA
    Neonatology; 2019; 116(3):236-243. PubMed ID: 31269508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survey of PDA management in very low birth weight infants across Italy.
    Ficial B; Corsini I; Fiocchi S; Schena F; Capolupo I; Cerbo RM; Condò M; Doni D; La Placa S; Porzio S; Rossi K; Salvadori S; Savoia M;
    Ital J Pediatr; 2020 Feb; 46(1):22. PubMed ID: 32059689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premature infants with patent ductus arteriosus: Postnatal growth according to type of management.
    Babla K; Dassios T; Pushparajah K; Hickey A; Greenough A
    Pediatr Neonatol; 2021 Jan; 62(1):36-40. PubMed ID: 32830076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective factors against preterm infants to develop significant patent ductus arteriosus.
    Huang HW; Lin C; Hsu KH; Hsu SY; Mok TY; Wu IH; Lai MY; Lien R
    Pediatr Neonatol; 2021 Jul; 62(4):379-386. PubMed ID: 33931344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying two distinct subphenotypes of patent ductus arteriosus in preterm infants using machine learning.
    Matsushita FY; Krebs VLJ; de Carvalho WB
    Eur J Pediatr; 2023 May; 182(5):2173-2179. PubMed ID: 36853570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Unintended Consequences of a Conservative Management Strategy for Patent Ductus Arteriosus.
    Elhoff JJ; Ebeling M; Hulsey TC; Atz AM
    Congenit Heart Dis; 2016; 11(1):52-7. PubMed ID: 26193967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conservative treatment for patent ductus arteriosus in the preterm.
    Vanhaesebrouck S; Zonnenberg I; Vandervoort P; Bruneel E; Van Hoestenberghe MR; Theyskens C
    Arch Dis Child Fetal Neonatal Ed; 2007 Jul; 92(4):F244-7. PubMed ID: 17213270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early prediction of spontaneous Patent Ductus Arteriosus (PDA) closure and PDA-associated outcomes: a prospective cohort investigation.
    Slaughter JL; Cua CL; Notestine JL; Rivera BK; Marzec L; Hade EM; Maitre NL; Klebanoff MA; Ilgenfritz M; Le VT; Lewandowski DJ; Backes CH
    BMC Pediatr; 2019 Sep; 19(1):333. PubMed ID: 31519154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-centre, randomised non-inferiority trial of early treatment versus expectant management of patent ductus arteriosus in preterm infants (the BeNeDuctus trial): statistical analysis plan.
    Hundscheid T; Donders R; Onland W; Kooi EMW; Vijlbrief DC; de Vries WB; Nuytemans DHGM; van Overmeire B; Mulder AL; de Boode WP;
    Trials; 2021 Sep; 22(1):627. PubMed ID: 34526095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic strategy of patent ductus arteriosus in extremely preterm infants.
    Su BH; Lin HY; Chiu HY; Tsai ML; Chen YT; Lu IC
    Pediatr Neonatol; 2020 Apr; 61(2):133-141. PubMed ID: 31740267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants.
    Mitra S; Scrivens A; von Kursell AM; Disher T
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013278. PubMed ID: 33301630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.